AbCellera Biologics Inc. (ABCL) Capital expenditures 2019–2025
AbCellera Biologics Inc. (ABCL) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$42.8MFY2025 · since FY2019: $4.0M → $42.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $42.8M | -45.4% |
| FY2024 | $78.4M | +1.9% |
| FY2023 | $76.9M | +8.9% |
| FY2022 | $70.7M | +20.9% |
| FY2021 | $58.5M | +504.3% |
| FY2020 | $9.7M | +142.0% |
| FY2019 | $4.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice